Raising the standard of care for women everywhere through the use of the most innovative technologies

Exosome Diagnostic Platform

Exosomes are at the cutting-edge of biotechnology research. We are developing a platform in conjunction with Dr. Thomas McElrath of Harvard Medical School to detect a multitude of women’s health problems in the Maternal Fetal space: PreTerm Birth, Preeclampsia, and Placenta Accreta.

Solution: Innovative Liquid Biopsy

We obtain and read tiny “info packets” (exosomes) shared back and forth by maternal and fetal tissues that sustain the “I’m OK, You’re OK” balances during the first trimester ( 10-12 weeks)

Multiomics Diagnostic Platform

With Dr. Daniel Chan and Dr. Zhen Zhang of Johns Hopkins Medical School, we are constructing a toolkit that can be used for the early detection of many types of cancer by employing the Multiomics/AI approach.

Future Cancer Diagnostics: Multi-Omics

Genomics, epigenomics, transcriptiomics, proteomics, phosphoproteomics, glycoproteomics, glycomics, immunomies, lipidomies, metabolomics, bioinformaties, etc.

Integration of genomic, epigenetic, transcriptomic, and proteomic data for comprehensive analysis of cell dynamics through multi-omics. Hristova VA and Chan DW. Cancer biomarker discovery and translation: proteomics and beyond. Expert Rev Proteomics (2019) 16:93-103.